NCT06622941View on ClinicalTrials.gov

Study to ONO-4538 in Patients With Rhabdoid Tumor

PHASE2RecruitingINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

November 25, 2024

Primary Completion Date

January 31, 2029

Study Completion Date

March 31, 2030

Conditions
Rhabdoid Tumor
Interventions
DRUG

ONO-4538

every 2 weeks

Trial Locations (3)

Unknown

RECRUITING

Nagoya University Hospital, Nagoya

RECRUITING

National Cancer Center Hospital, Chuo-ku

RECRUITING

Osaka City General Hospital, Osaka

Sponsors
All Listed Sponsors
lead

Ono Pharmaceutical Co. Ltd

INDUSTRY